Our clozapine group differed from our control group in weight gain, food efficiency, adipocyte size, fat tissue weight, renal and retinal pathology, serum AST and ALT levels, serum and hepatic triglyceride levels, and fatty liver disease severity. The gene discussed is GPT; the disease is fatty liver disease.